False-positive screening results in the Finnish prostate cancer screening trial

BACKGROUND: There is evidence that prostate cancer (PC) screening with prostate-specific antigen (PSA) serum test decreases PC mortality, but screening has adverse effects, such as a high false-positive (FP) rate. We investigated the proportion of FPs in a population-based randomised screening trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Kilpeläinen, T P, Tammela, T L J, Määttänen, L, Kujala, P, Stenman, U-H, Ala-Opas, M, Murtola, T J, Auvinen, A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2822946/
https://www.ncbi.nlm.nih.gov/pubmed/20051951
http://dx.doi.org/10.1038/sj.bjc.6605512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2822946/
https://www.ncbi.nlm.nih.gov/pubmed/20051951
http://dx.doi.org/10.1038/sj.bjc.6605512

Ejemplares similares